Patricia Giblin
Chief Scientific Officer Ability Biologics
Seminars
Wednesday 4th November 2026
Accelerating Time to Proof-of-Concept to De-Risk Dermatology Pipelines & Unlock Faster Decision-Making
4:25 pm
- Reducing time to proof-of-concept through optimized early study design, enabling faster signal detection, to accelerate go/no-go decisions and reduce R&D spend
- Identifying tools to detect early efficacy signals in large patient cohorts, improving trial efficiency, to minimize costly late-stage failures
- Streamlining development pathways for systemic and early-stage assets, enhancing operational speed, to bring therapies to patients faster
